Ingersoll Rand Inc. (NYSE: IR), a $32.5 billion industrial giant, completed the acquisition of U.S.-based lab automation specialist Scinomix, Inc. on January 5, 2026, at an attractive pre-synergy...
Samsung Biologics America (SBA), a wholly owned subsidiary of South Korea's leading contract development and manufacturing organization (CDMO), has agreed to acquire 100% of Human Genome Sciences...
Royal Philips (NYSE: PHG), a global leader in medical technology, has agreed to acquire SpectraWAVE, Inc., a Massachusetts-based innovator in **AI-powered intravascular imaging**, to bolster its...
Nippon Life Insurance Co. is pursuing an acquisition of a Japanese medical‑data firm, marking what executives describe as a strategic milestone as the insurer shifts from traditional asset...
Japanese pharmaceutical companies are increasingly pursuing mergers and acquisitions (M&A) beyond their domestic borders, targeting strategic assets in the United States and Europe to drive growth...
Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, announced a strategic divestiture of its Acute Care, Interventional Urology, and Original Equipment Manufacturing (OEM)...
Mirum Pharmaceuticals (Nasdaq: MIRM), a leading rare disease biopharma, announced a definitive agreement to acquire Bluejay Therapeutics, a privately held biotech focused on viral and liver...
Biotechnology major Biocon has announced a strategic corporate action to fully integrate Biocon Biologics Limited (BBL) as a wholly owned subsidiary into Biocon Limited, valuing the biologics unit...
AbbVie's recent acquisition of Gilgamesh Pharmaceuticals' psychedelic depression treatment for up to $1.2 billion represents a pivotal moment in the pharmaceutical giant's post-Humira...
